Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Thursday, November 21, 2024.
CytomX Therapeutics, Inc. (NASDAQ:CTMX)
Long-Term Downtrend (-90) - CTMX is in a strong downtrend that is likely to continue. While CTMX is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid CTMX?
MarketClub looks at technical strength and momentum to determine if the timing is right for CTMX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CTMX
The long-term trend has been DOWN since Jun 11th, 2024 at 1.5800
The intermediate-term trend has been DOWN since Oct 3rd, 2024 at 1.1101
The short-term trend has been DOWN since Nov 11th, 2024 at 0.9801
Smart Scan Analysis for CTMX
Based on our trend formula, CTMX is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 0.9000 | 0.9200 | 0.8513 | 0.8701 | -0.0226 |
| Prev. Close | Volume | Bid | Ask | Time |
| 0.8701 | 422432 | 2024-11-20 15:59:29 |
| Year High | 35 | Year High Date | 2018-03-08 |
| Year Low | 12.51 | Year Low Date | 2018-11-20 |
| 52wk High | 5.85 | 52wk High Date | 2024-05-01 |
| 52wk Low | 0.833 | 52wk Low Date | 2024-11-19 |
| Average Volume | 1,149,050 | Shares Outstanding | 78,259 |
| Market Cap | 450M | Assets | 159,219,000M |
| Liabilities | 190,446,000M | P/E Ratio | 6.3764 |
| Volatility | 104.36 |